FDA Inspection 1102672 — Kaiser Permanente Center for Reproductive Health

Kaiser Permanente Center for Reproductive Health — FEI 3004740553

The FDA completed an inspection of Kaiser Permanente Center for Reproductive Health on September 12, 2019 in Fremont, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fremont, CA (United States)